{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:00:18Z","timestamp":1781290818409,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05570-z","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T10:23:55Z","timestamp":1710843835000},"page":"2607-2612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9268-0088","authenticated-orcid":false,"given":"Anna","family":"Maeser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4848-2971","authenticated-orcid":false,"given":"Malgorzata","family":"Biernacka-Zielinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-0448","authenticated-orcid":false,"given":"Elzbieta","family":"Smolewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"2","key":"5570_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4274\/balkanmedj.2017.0111","volume":"34","author":"K Barut","year":"2017","unstructured":"Barut K, Adrovic A, \u015eahin S, Kasap\u00e7opur \u00d6 (2017) Juvenile idiopathic arthritis. Balkan Med J. 34(2):90\u2013101","journal-title":"Balkan Med J."},{"key":"5570_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, Midgley A, Christmas SE et al (2021) Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol 19:135. https:\/\/doi.org\/10.1186\/s12969-021-00629-8","journal-title":"Pediatr Rheumatol"},{"key":"5570_CR3","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00296-016-3545-9","volume":"36","author":"S Ayta\u00e7","year":"2016","unstructured":"Ayta\u00e7 S, Batu ED, \u00dcnal \u015e et al (2016) Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int 36:1421\u20131429. https:\/\/doi.org\/10.1007\/s00296-016-3545-9","journal-title":"Rheumatol Int"},{"key":"5570_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OARRR.S151013","volume":"10","author":"B Lerkvaleekul","year":"2018","unstructured":"Lerkvaleekul B, Vilaiyuk S (2018) Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol Res Rev 10:117\u2013128. https:\/\/doi.org\/10.2147\/OARRR.S151013","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"9","key":"5570_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","volume":"11","author":"RQ Cron","year":"2015","unstructured":"Cron RQ, Davi S, Minoia F, Ravelli A (2015) Clinical features and correct diagnosis of macrophage activation syndrome. Expert Rev Clin Immunol 11(9):1043\u20131053. https:\/\/doi.org\/10.1586\/1744666X.2015.1058159","journal-title":"Expert Rev Clin Immunol"},{"key":"5570_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou P, Kadavath S, Mehta B (2014) Life-threatening complications of adult-onset Still\u2019s disease. Clin Rheumatol 33:305\u2013314. https:\/\/doi.org\/10.1007\/s10067-014-2487-4","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5570_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","volume":"160","author":"M Shimizu","year":"2015","unstructured":"Shimizu M, Nakagishi Y, Inoue N, Mizuta M, Ko G, Saikawa Y, Kubota T, Yamasaki Y, Takei S, Yachie A (2015) Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clin Immunol 160(2):277\u2013281. https:\/\/doi.org\/10.1016\/j.clim.2015.06.005","journal-title":"Clin Immunol"},{"issue":"13","key":"5570_CR8","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","volume":"131","author":"ES Weiss","year":"2018","unstructured":"Weiss ES, Girard-Guyonvarch C, Holzinger D, de Jesus AA, Tariq Z, Picarsic E, Schiffrin EJ, Foell D, Grom AA, Ammann S, Ehl S, Hoshino T, Goldbach-Mansky R, Gabay C, Canna SW (2018) Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 131(13):1442\u20131455. https:\/\/doi.org\/10.1182\/blood-2017-12-820852","journal-title":"Blood."},{"issue":"1","key":"5570_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-016-1069-z","volume":"18","author":"F Gohar","year":"2016","unstructured":"Gohar F, Kessel C, Lavric M, Holzinger D, Foell D (2016) Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks? Arthritis Res Ther 18(1):1\u201312. https:\/\/doi.org\/10.1186\/s13075-016-1069-z","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5570_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","volume":"44","author":"KMK Kostik","year":"2015","unstructured":"Kostik KMK, Dubko MG, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Likhacheva TS, Isupova EA, Glebova NI, Kuchinskaya EM, Balbotkina EV, Buchinskaya NV, Kalashnikova OV, Chasnyk VG (2015) Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semin Arthritis Rheum 44(4):417\u2013422. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.09.004","journal-title":"Semin Arthritis Rheum"},{"key":"5570_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, Pistorio A, Aric\u00f2 M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter J-I, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ (2016) Classification criteria for macrophage activation syndrome complicating systemic Juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol 68:566\u2013576. https:\/\/doi.org\/10.1002\/art.39332","journal-title":"Arthritis Rheumatol"},{"key":"5570_CR12","doi-asserted-by":"publisher","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","volume":"2","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S et al (2016) Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open. 2:e000161. https:\/\/doi.org\/10.1136\/rmdopen-2015-000161","journal-title":"RMD Open."},{"key":"5570_CR13","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao Y-J, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic Juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66:3160\u20133169. https:\/\/doi.org\/10.1002\/art.38802","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"5570_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3899\/jrheum.141567","volume":"42","author":"M Pardeo","year":"2015","unstructured":"Pardeo M, Marafon DP, Insalaco A, Bracaglia C, Nicolai R, Messia V, De Benedetti F (2015) Anakinra in systemic juvenile idiopathic arthritis: a single-center experience. J Rheumatol 42(8):1523\u20131527. https:\/\/doi.org\/10.3899\/jrheum.141567","journal-title":"J Rheumatol"},{"issue":"1","key":"5570_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/rheumatology\/key262","volume":"58","author":"L Kearsley-Fleet","year":"2019","unstructured":"Kearsley-Fleet L, Beresford MW, Davies R, De Cock D, Baildam E, Foster HE, Southwood TR, Thomson W, Hyrich KL (2019) Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra. Rheumatology 58(1):94\u2013102. https:\/\/doi.org\/10.1093\/rheumatology\/key262","journal-title":"Rheumatology"},{"key":"5570_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/art.41103","volume":"72","author":"EM Eloseily","year":"2020","unstructured":"Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, Beukelman T, Atkinson TP, Cron RQ (2020) Benefit of Anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol 72:326\u2013334. https:\/\/doi.org\/10.1002\/art.41103","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"5570_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3899\/jrheum.210563","volume":"49","author":"G Giancane","year":"2022","unstructured":"Giancane G, Papa R, Vastert S, Bagnasco F, Swart JF, Quartier P et al (2022) Anakinra in Patients with systemic juvenile idiopathic arthritis: long-term safety from the pharmachild registry. The Journal of Rheumatol. 49(4):398\u2013407. https:\/\/doi.org\/10.3899\/jrheum.210563","journal-title":"The Journal of Rheumatol."},{"key":"5570_CR18","first-page":"014","volume":"1","author":"T Peng","year":"2015","unstructured":"Peng T, Kwong J, Cron R, Chefitz D, Mohinuddin A (2015) Treatment of refractory macrophage activation syndrome in systemic juvenile idiopathic arthritis with high dose anakinra. J Rheum Dis Treat 1:014","journal-title":"J Rheum Dis Treat"},{"key":"5570_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12969-021-00585-3","volume":"19","author":"O Phadke","year":"2021","unstructured":"Phadke O, Rouster-Stevens K, Giannopoulos H et al (2021) Intravenous administration of anakinra in children with macrophage activation syndrome. Pediatr Rheumatol 19:98. https:\/\/doi.org\/10.1186\/s12969-021-00585-3","journal-title":"Pediatr Rheumatol"},{"key":"5570_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105524","author":"S Bindoli","year":"2023","unstructured":"Bindoli S, Galozzi P, Doria A, Sfriso P (2023) Intravenous Anakinra to curb cytokine storm in adult-onset still\u2019s disease and in macrophage activation syndrome: a case series. Joint Bone Spine. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105524","journal-title":"Joint Bone Spine"},{"key":"5570_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/art.39407","volume":"68","author":"AA Grom","year":"2016","unstructured":"Grom AA, Ilowite NT, Pascual V, Brunner HI, Martini A, Lovell D, Ruperto N, Leon K, Lheritier K, Abrams K (2016) Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab. Arthritis Rheumatol 68:218\u2013228. https:\/\/doi.org\/10.1002\/art.39407","journal-title":"Arthritis Rheumatol"},{"key":"5570_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/acr.23277","volume":"70","author":"GS Schulert","year":"2018","unstructured":"Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, Kon\u00c9-Paut I, Kostik M, Lovell D, Maritsi D, Nigrovic PA, Pal P, Ravelli A, Shimizu M, Stanevicha V, Vastert S, Woerner A, de Benedetti F, Grom AA (2018) Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. Arthritis Care Res 70:409\u2013419. https:\/\/doi.org\/10.1002\/acr.23277","journal-title":"Arthritis Care Res"},{"key":"5570_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05570-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:25:11Z","timestamp":1727299511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05570-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["5570"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05570-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"27 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient\u2019s parents gave their consent to describe their child\u2019s case and publish the photos for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}